A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker
Clinical trial NCT01137474 · COMPLETED
Trial details
- NCT number
- NCT01137474
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2013-02-01
- Enrollment
- 2996
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.